126 related articles for article (PubMed ID: 9301894)
1. [Monoclonal antibodies directed to human lung cancer].
Kannagi R; Miyake M; Itai S; Naito M; Hashimoto K
Rinsho Kyobu Geka; 1989 Feb; 9(1):19-28. PubMed ID: 9301894
[TBL] [Abstract][Full Text] [Related]
2. Clinical observations on the association between diagnosis of lung cancer and serum tumor markers in combination.
Wang WJ; Tao Z; Gu W; Sun LH
Asian Pac J Cancer Prev; 2013; 14(7):4369-71. PubMed ID: 23992005
[TBL] [Abstract][Full Text] [Related]
3. History, molecular features, and clinical importance of conventional serum biomarkers in lung cancer.
Nakamura H; Nishimura T
Surg Today; 2017 Sep; 47(9):1037-1059. PubMed ID: 28229299
[TBL] [Abstract][Full Text] [Related]
4. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
5. Serum levels of neuron-specific enolase, carbohydrate antigen 19-9 and carbohydrate antigen 125 in carcinoma of the lung.
Oktay G; Güner G; Karlikaya C; Akkoçlu A
Biochem Soc Trans; 1995 May; 23(2):211S. PubMed ID: 7672232
[No Abstract] [Full Text] [Related]
6. [A statistical analysis of serum sialyl Lewis X-1 (SLX), CEA, SCC and NSE levels in patients with lung cancer].
Ueoka H; Ohnoshi T; Moritaka T; Kiura K; Mima Y; Horiguchi T; Segawa Y; Tabata M; Shibayama T; Maeda T
Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Aug; 29(8):1022-8. PubMed ID: 1684395
[TBL] [Abstract][Full Text] [Related]
7. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
Shitara K; Hanai N; Yoshida H
Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
[TBL] [Abstract][Full Text] [Related]
8. [Cancer-associated mucin detected by monoclonal anti-carbohydrate antibodies].
Kannagi R; Fukushi Y; Hakomori S
Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):812-25. PubMed ID: 2870685
[TBL] [Abstract][Full Text] [Related]
9. [Neuron-specific enolase (NSE) and squamous cell carcinoma antigen (SCC) as serum markers in the diagnosis of bronchial carcinoma].
Lorenz J; Gillmann-Blum D; Jensen M; Kreienberg R
Pneumologie; 1990 Nov; 44(11):1259-63. PubMed ID: 2177891
[TBL] [Abstract][Full Text] [Related]
10. Tumor markers in patients with chronic renal failure.
Filella X; Cases A; Molina R; Jo J; Bedini JL; Revert L; Ballesta AM
Int J Biol Markers; 1990; 5(2):85-8. PubMed ID: 1704405
[TBL] [Abstract][Full Text] [Related]
11. The prognostic value of both neuron-specific enolase (NSE) and Cyfra21-1 in small cell lung cancer.
Ando S; Suzuki M; Yamamoto N; Iida T; Kimura H
Anticancer Res; 2004; 24(3b):1941-6. PubMed ID: 15274381
[TBL] [Abstract][Full Text] [Related]
12. Distribution of lung adenocarcinoma-associated antigens in human tissues and sera defined by monoclonal antibodies KM-52 and KM-93.
Shitara K; Hanai N; Yoshida H
Cancer Res; 1987 Mar; 47(5):1267-72. PubMed ID: 3545444
[TBL] [Abstract][Full Text] [Related]
13. [Determination of various tumor markers, with special reference to neuron-specific enolase in lung cancer].
Yano H; Hino M; Nishiwaki Y; Kodama T; Hayashibe A; Kudo H; Inoue Y; Nishiyama Y; Sone Y; Oshima T
Gan To Kagaku Ryoho; 1987 Jan; 14(1):77-83. PubMed ID: 3026257
[TBL] [Abstract][Full Text] [Related]
14. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
[TBL] [Abstract][Full Text] [Related]
15. [Importance of serum TPA determination in bronchopulmonary cancer. A comparative study of CEA, CA 19.9 and NSE].
Prévost A; Passemard F; Perdu D; Vallerand H; Deschamps F; Lavaud F; Larbre H
Rev Mal Respir; 1994; 11(4):379-84. PubMed ID: 7973038
[TBL] [Abstract][Full Text] [Related]
16. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
Hui L; Rixv L; Xiuying Z
Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
[TBL] [Abstract][Full Text] [Related]
17. Comparative studies of CAM 123-6 and carcinoembryonic antigen for the serological detection of pulmonary adenocarcinoma.
Kohno N; Hirasawa Y; Kondo K; Fujioka S; Fujino S; Abe M; Yokoyama A; Hiwada K; Watanabe K; Nishimura J
Cancer Detect Prev; 1997; 21(2):124-8. PubMed ID: 9101072
[TBL] [Abstract][Full Text] [Related]
18. Optimal combination of seven tumour markers in prediction of advanced stage at first examination of patients with non-small cell lung cancer.
Ando S; Kimura H; Iwai N; Shima M; Ando M; Kuriyama T
Anticancer Res; 2001; 21(4B):3085-92. PubMed ID: 11712815
[TBL] [Abstract][Full Text] [Related]
19. Early diagnosis of lung cancer in the elderly using four tumor markers and serum ferritin for better surgical management.
Yang J; Lin L; Jiang W; Wu J; Lin X
Asian J Surg; 2020 Nov; 43(11):1088-1089. PubMed ID: 33097393
[No Abstract] [Full Text] [Related]
20. Diagnostic value of bronchoalveolar lavage fluid and serum tumor markers for lung cancer.
Wang H; Zhang X; Liu X; Liu K; Li Y; Xu H
J Cancer Res Ther; 2016; 12(1):355-8. PubMed ID: 27072263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
